Skip to main content
OpenTrials
Completed

NCT Number: NCT05684887

Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon

According to the WHO, contact tracing - along with robust testing, isolation, and care of cases is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19. Contact tracing, however, has a number of challenges. These include incomplete identification of contacts, inefficiencies in paper-based reporting systems, complex data management requirements, and delays in the identification of contacts and testing of contacts. In many settings, contact tracing has proven to be too resource-intensive to implement at scale, especially with higher levels of community transmission, highlighting the need for more efficient contact tracing approaches. Digital tools afford the possibility of strengthening contact tracing for COVID-19, in a more efficient way. However, there is limited evidence of the effectiveness and impact of these tools in the COVID-19 response, including contact tracing.

This study proposes to compare the cascade of care between two strategies for COVID-19 contact tracing of SARS-CoV-2 infected index patients in Cameroon. In one strategy (intervention), the health facilities and health district testing units will implement contact tracing using a digital tool developed to support the tracing and testing of contacts (addition of a digital contact tracing module to the main platform for COVID-19 testing in Cameroon (Mamal Pro app)). This strategy will be compared to the standard contact tracing process (control), based on the current routine approach (use of the Mamal Pro application without the digital contact tracing module).

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bonanjo Integrated Health Center, Douala, Littoral Region, Cameroon

Loading trial locations.

About this study

The study's general objective is to assess the effectiveness, feasibility, acceptability, and cost associated with the addition of a Mamal Pro digital contact tracing module to the Mamal Pro app in improving COVID-19 contact tracing and testing in Littoral, Cameroon.

Specific objectives are:

  • Primary objective: To determine the effectiveness of the use of a Mamal Pro digital contact tracing module added to the Mamal Pro app in improving COVID-19 contact tracing and testing compared to the SOC as measured by:
  • The number and proportion of reported contacts who received SARS-CoV-2 testing.
  • The number and proportion of contacts who are successfully reached by phone by MOH district contact tracing unit.
  • The number and proportion of contacts testing positive for SARS-CoV-2 infection.
  • The time from SARS-CoV-2 infected index patient identification of contacts to communication with the contact by the district contact tracing unit.
  • Secondary objectives:
  • To assess the feasibility and acceptability of the use of the Mamal Pro digital contact tracing module through structured interviews with MOH facility staff, district unit contract tracing teams, and individuals undergoing SARS-CoV-2 testing.
  • To estimate the total cost of using the Mamal Pro contact tracing module for tracing SARS-CoV2 positive case contacts and cost per contact traced using the module.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All contacts listed by individuals registered in the Mamal Pro app for testing, who test positive for SARS-CoV-2 in the selected health district testing units and health facilities in Cameroon.

Exclusion criteria

  • None

Treatment and study plan

Digital based contact tracing

Other
  • Listing of contacts by SARS-CoV-2 positive individuals in Mamal Pro app + verification and validation by a health care worker.
  • Immediate access to the contact list in Mamal Pro once validated by the health care worker.
  • Contacts are immediately notified by text message automatically sent to all contacts with phone numbers and later called by the HCWs responsible for carrying out the contact tracing at the district level.
  • Contacts will be invited to go to the nearest testing facilities/units to get tested.
  • Those who are unable or refuse to come for testing are followed up by phone for 10 days for the occurrence of COVID-19 symptoms.
  • Information about the contact tracing process during communication with contacts are recorded in Mamal Pro digital contact tracing module.

Primary outcomes

  1. Successful contact tracing

    Time frame: 10 days

    The primary outcome is the proportion of contacts declared by the index case who are successfully called by the district contact tracing unit and the proportion of contacts who receive SARS-CoV-2 testing, as per MOH standard testing procedures.

Secondary outcomes

  1. Contacts testing positive for SARS-CoV-2 infection.

    Time frame: 10 days

    The proportion of contacts testing positive for SARS-CoV2 infection

  2. Feasibility of the intervention model of contact tracing

    Time frame: 4 months

    • ease of use
    • time to complete the process in the Mamal Pro digital contact tracing module
    • integration with other clinic activities
  3. Acceptability intervention model of contact tracing by the index cases (negative and positive) and health care workers

    Time frame: 4 months

    • satisfaction of using the Mamal Pro digital contact tracing module compared with the usual standard of care approach
    • challenges with this approach to contact tracing
    • suggestions for improvement.
  4. Cost of the intervention

    Time frame: 4 months

    Cost estimates for using Mamal Pro digital contact tracing module to trace contacts, and cost per contact traced.

  5. Timely communication with contacts

    Time frame: 4 months

    Time (days) between receipt of contact list and contacts' call attempts

  6. SMS sent

    Time frame: 4 months

    Proportion of SMS delivered, (numerator: SMS sent, denominator: phone numbers)

Sponsors and collaborators

Lead sponsor

Elizabeth Glaser Pediatric AIDS Foundation

Other

Collaborators

  • Cameroon Ministry of Public Health
  • Find

Registry information

Official study title

Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon (DTECT Cameroon)

Acronym: DTECT

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 13, 2023
Registry last updated
Dec 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.